Teladoc, Inc. (NYSE:TDOC) has been given a consensus rating of “Buy” by the fifteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and ten have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $37.30.

A number of analysts have weighed in on the company. BidaskClub upgraded Teladoc from a “sell” rating to a “hold” rating in a research report on Wednesday. Canaccord Genuity reiterated a “buy” rating and issued a $42.00 price target (up from $34.00) on shares of Teladoc in a research report on Tuesday, June 20th. Chardan Capital upped their price target on Teladoc from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, June 20th. Craig Hallum cut Teladoc from a “buy” rating to a “hold” rating and upped their price target for the company from $28.00 to $32.00 in a research report on Friday, May 12th. Finally, Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $40.00 price target (up from $27.00) on shares of Teladoc in a research report on Friday, June 9th.

TRADEMARK VIOLATION NOTICE: “Teladoc, Inc. (NYSE:TDOC) Receives Average Rating of “Buy” from Brokerages” was first published by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/12/teladoc-inc-nysetdoc-receives-average-rating-of-buy-from-brokerages.html.

In related news, VP Mark Hirschhorn sold 100,000 shares of the company’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $27.70, for a total value of $2,770,000.00. Following the completion of the sale, the vice president now owns 80,887 shares in the company, valued at $2,240,569.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Adam C. Vandervoort sold 53,806 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $30.92, for a total value of $1,663,681.52. Following the completion of the sale, the insider now owns 33,008 shares of the company’s stock, valued at approximately $1,020,607.36. The disclosure for this sale can be found here. Insiders have sold 207,186 shares of company stock worth $6,122,950 in the last ninety days. 5.94% of the stock is currently owned by insiders.

A number of large investors have recently added to or reduced their stakes in TDOC. State Street Corp increased its stake in Teladoc by 2.5% in the fourth quarter. State Street Corp now owns 381,703 shares of the health services provider’s stock worth $6,309,000 after buying an additional 9,146 shares in the last quarter. Teachers Advisors LLC increased its stake in Teladoc by 5.3% in the fourth quarter. Teachers Advisors LLC now owns 35,205 shares of the health services provider’s stock worth $581,000 after buying an additional 1,759 shares in the last quarter. First Mercantile Trust Co. bought a new stake in Teladoc during the first quarter worth approximately $175,000. Russell Investments Group Ltd. bought a new stake in Teladoc during the first quarter worth approximately $583,000. Finally, Wells Fargo & Company MN increased its stake in Teladoc by 43.8% in the first quarter. Wells Fargo & Company MN now owns 543,568 shares of the health services provider’s stock worth $13,589,000 after buying an additional 165,435 shares in the last quarter. Institutional investors and hedge funds own 95.88% of the company’s stock.

Shares of Teladoc (TDOC) opened at 30.35 on Friday. The company’s market capitalization is $1.72 billion. The firm has a 50-day moving average price of $33.88 and a 200-day moving average price of $27.52. Teladoc has a 1-year low of $14.00 and a 1-year high of $36.90.

Teladoc (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.02. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The company had revenue of $44.60 million during the quarter, compared to the consensus estimate of $44.39 million. During the same quarter last year, the company earned ($0.38) earnings per share. The business’s revenue was up 68.3% on a year-over-year basis. Equities analysts anticipate that Teladoc will post ($1.47) earnings per share for the current year.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.